| Impact of pharmacogenomics on the clinical laboratory P Hess, D Cooper Molecular Diagnosis 4 (4), 289-298, 1999 | 34 | 1999 |
| Use of computationally derived protein structures of genetic polymorphisms in pharmacogenomics for drug design and clinical applications K Ramnarayan, E Maggio, P Hess US Patent App. 10/271,181, 2003 | 25 | 2003 |
| China’s Financial System: Past Reforms, Future Ambitions and Current State P Hess Currency Cooperation in East Asia, 21-41, 2014 | 14 | 2014 |
| Gene therapy: a brief review P Hess Clinics in laboratory medicine 16 (1), 197-211, 1996 | 12 | 1996 |
| The ongoing evolution of payment instruments in China: A case study in financial innovation, and on the role of the central bank P Hess Cash in East Asia, 117-131, 2017 | 8 | 2017 |
| Securities Clearing and Settlement in China: Markets, Infrastructures and Policy-Making P Hess ECB Occasional Paper Series, 1-31, 2010 | 8 | 2010 |
| Reformen, Status und Perspektiven des chinesischen Finanzsystems P Hess Länderbericht China, 775-803, 2014 | 3 | 2014 |
| CLAS 27TH NATIONAL MEETING SYLLABUS-Structural Pharmacogenomic Approach to the Evaluation of Drug Resistant Mutations in HIV-1 Protease M Shenderovich, K Ramnarayan, R Kagan, P Hess Journal of Clinical Ligand Assay 24 (2), 140-144, 2001 | 3 | 2001 |
| Gene therapy monitoring: clinical monitoring for efficacy and potential toxicity P Hess, GJ Dougherty Molecular Diagnosis 2 (2), 147-155, 1997 | 3 | 1997 |
| China’s monetary policy: Institutional setting, tools and challenges P Hess Monetary Policy Implementation in East Asia, 13-30, 2020 | 2 | 2020 |
| Demand and Supply of Shadow Banking in China X Zhang, P Hess Central Banking and Financial Stability in East Asia, 141-156, 2015 | 1 | 2015 |
| Use of computationally derived protein structures of genetic polymorphisms in pharmacogenomics for drug design and clinical applications K Ramnarayan, E Maggio, P Hess US Patent App. 11/229,393, 2006 | 1 | 2006 |
| The supervision and regulation of climate risks for banks: overview from the perspective of a European practitioner P Hess Green Finance 4 (3), 295-309, 2022 | | 2022 |
| The editorial staff wishes to express its gratitude to the following individuals for their excellent critical reviews for Molecular Diagnosis these past two years: Maria E … H Aviv, A Bagg, D Baldwin, WP Bennett, JA Biegel, R Braziel, MP Busch, ... Molecular Diagnosis 6 (4), 2001 | | 2001 |
| The editorial staff wishes to express its gratitude to the individuals below for their excellent critical reviews for Molecular Diagnosis these past two years. A Anguiano, DA Arber, D Asman, A Bagg, RR Barathur, S Barthold, ... Molecular Diagnosis 4 (4), 1999 | | 1999 |
| The editorial staff wishes to express its gratitude to the individuals listed below who served as guest re-viewers during the past year. Douglas Anthony, MD, PhD Robert Bowser, PhD R Braziel, D Coppola, AC Hassett, D Crisan, GJ Dougherty, R Deka, ... Molecular Diagnosis 2 (4), 1997 | | 1997 |
| Un approccio di farmacogenetica strutturale alla valutazione delle mutazioni di farmaco-resistenza nella proteasi di HIV-1 M Shenderovich, K Ramnarayan, R Kagan, P Hess CLINICAL LIGAND ASSAY, 143, 0 | | |
